Qube Research & Technologies (QRT)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Qube Research & Technologies (QRT)'s URGN Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in UroGen Pharma (URGN) in Q3 2026: 287,222 shares worth $11.7M. The stake represents 0.01% of the portfolio and ranks #1345 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in URGN as recently as Q1 2023.
Qube Research & Technologies (QRT) first reported a position in URGN in Q2 2022 and has held it in 5 quarters since. 207 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Qube Research & Technologies (QRT) held 287,222 shares of UroGen Pharma worth $11.7M as of Q3 2026.
- UroGen Pharma was a new Qube Research & Technologies (QRT) position in Q3 2026.
- UroGen Pharma made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1345 holding.
- Qube Research & Technologies (QRT) first reported a position in UroGen Pharma in Q2 2022 and has held it in 5 quarters since.
- 207 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.